COG4 inhibitors are a class of chemical compounds designed to interfere with the function of the Conserved Oligomeric Golgi (COG) complex, specifically targeting the COG4 subunit. The COG complex is a multisubunit protein assembly essential for maintaining the structure and function of the Golgi apparatus, a critical organelle involved in the sorting, modification, and trafficking of proteins and lipids within the cell. COG4 is one of the eight subunits that make up this complex and plays a pivotal role in the tethering and fusion of vesicles to the Golgi membrane, facilitating proper intracellular transport and ensuring the fidelity of glycosylation processes. Inhibitors of COG4 are typically small molecules or peptides designed to disrupt the normal function of this subunit, thereby affecting the overall activity of the COG complex and altering intracellular trafficking pathways.
The design and function of COG4 inhibitors revolve around their ability to bind specifically to the COG4 subunit, either at its active site or at a critical interaction interface with other proteins or subunits of the COG complex. By binding to COG4, these inhibitors can prevent the subunit from participating in its normal roles, such as vesicle docking or protein sorting within the Golgi apparatus. This disruption can lead to a cascade of effects within the Golgi complex, including alterations in Golgi structure, mislocalization of Golgi enzymes, and disruption of glycosylation patterns, which are crucial for proper protein function. The development of COG4 inhibitors requires detailed knowledge of the COG complex's structure, particularly the COG4 subunit, and its interactions with other proteins. This involves advanced techniques in molecular modeling, crystallography, and biochemical assays to identify and optimize compounds that can effectively inhibit COG4. The specificity of these inhibitors is crucial to ensure they target COG4 without affecting other components of the Golgi apparatus or similar cellular machinery, which necessitates rigorous testing and refinement during their development.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $152.00 $515.00 | ||
A polyether antibiotic that disrupts Golgi function by altering cation transport, which can interfere with COG4 function as it is involved in Golgi apparatus maintenance. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
A lactone that inhibits protein transport from the endoplasmic reticulum to the Golgi apparatus, affecting COG4-related trafficking processes. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $58.00 $83.00 $140.00 $242.00 | 38 | |
A synthetic compound that disrupts microtubule polymerization, potentially affecting vesicular trafficking and COG4's role in it. | ||||||
Golgicide A | 1005036-73-6 | sc-215103 sc-215103A | 5 mg 25 mg | $187.00 $670.00 | 11 | |
A specific inhibitor of the Golgi BFA resistance factor 1 (GBF1), which can affect COG4-dependent Golgi processing by disrupting the ARF1-COG complex interaction. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $87.00 | 44 | |
A small molecule that inhibits dynamin, potentially affecting COG4 function due to dynamin's role in membrane fission, a process necessary for vesicle trafficking. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $145.00 $442.00 | 64 | |
An actin polymerization inhibitor, which can affect cytoskeletal dynamics and thus potentially influence COG4-dependent vesicle transport. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $134.00 $502.00 | 7 | |
A selective inhibitor of the Cdc42 GTPase, potentially affecting COG4 function as Cdc42 is involved in Golgi apparatus organization. | ||||||
Latrunculin B | 76343-94-7 | sc-203318 | 1 mg | $229.00 | 29 | |
A toxin that binds to actin monomers, preventing polymerization and potentially influencing COG4's role in vesicle movement through effects on the cytoskeleton. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $40.00 $73.00 $217.00 $242.00 $724.00 $1196.00 | 39 | |
A compound that stabilizes microtubules, potentially affecting COG4 function by altering microtubule dynamics required for vesicular trafficking. | ||||||
Swinholide A, Theonella swinhoei | 95927-67-6 | sc-205914 | 10 µg | $135.00 | ||
A marine compound that severs actin filaments, potentially affecting COG4-mediated vesicle transport by altering actin cytoskeleton architecture. | ||||||